Hjem › Blærecancer › Wisconsin
Blærecancer kliniske forsøg i Wisconsin
17 studier for Blærecancer søger deltagere på steder i Wisconsin.
Byer i Wisconsin
- Milwaukee11 studier
- Green Bay6 studier
- Madison4 studier
- Racine4 studier
- Wausau4 studier
- Sheboygan3 studier
- Oshkosh3 studier
- Stevens Point3 studier
Officiel studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- og 50 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- og 5 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
- Ascension Calumet Hospital-Chilton, Chilton
- og 11 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- og 25 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT03866382ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
RekruttererFrivillige med god helbredstilstand velkomne
Alder 45 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06995898Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07227077Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Langlade Hospital and Cancer Center, Antigo
- Cancer Center of Western Wisconsin, New Richmond
- Aspirus Cancer Care - James Beck Cancer Center, Rhinelander
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07097142A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Froedtert Hospital / Medical College of Wisconsin, Milwaukee
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT04752722An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Milwaukee
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT04879329Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- University of Wisconsin-Madison, Madison
Rekrutterer
Alder 18 til 88 · Alle køn · Opdateret 2. jul. 2026 · NCT06394869Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Medical College of Wisconsin, Milwaukee
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. mar. 2026 · NCT04075305SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.